Table 1.

Baseline participant characteristics

	Prior, Anti-VEGF (N = 20)	Anti-VEGF, Naïve (N = 20)	Total (N = 45)
Age, y
Median	54.18	54.35	54
Range	22.5–69.41	25.9–72.7	22.5–80.4
Sex, n (%)
Male	14 (70)	14 (70)	33 (73)
Female	6 (30)	6 (30)	12 (27)
Karnofsky performance status
Median	80%	80%	80%
Range	60%–100%	60%–100%	60%–100%
Mini-mental score
Median	27	29	29
Range	17–30	22–30	17–30
Anticonvulsant, n (%)
Yes	15 (75)	13 (65)	33 (73)
No	5 (25)	7 (35)	12 (27)